Strategies for Effectively Enhancing IP Value of Critical Assets After Teva v. Amneal and Other Recent Decisions
June 11, 2025
Webinar
Intellectual Property Resources, Ltd (IPR)
As part of the Intellectual Property Resources (IPR) webinar series, Finnegan attorneys Scott Forman, Jeffrey Jacobstein, Laura Masurovsky, and Lauren Robinson will discuss strategies for navigating recent court decisions to obtain IP protection for critical life sciences assets. For more information, or to register, please see the IPR’s website.
Tags
United States Court of Appeals for the Federal Circuit (CAFC), Food and Drug Administration (FDA), Orange Book
